Research publications

Tuberculosis in Australia's tropical north: a population-based genomic epidemiological study

Meumann, EM; Horan, K; Ralph, AP; Farmer, B; Globan, M; Stephenson, E; Popple, T; Boyd, R; Kaestli, M; Seemann, T; Vandelannoote, K; Lowbridge, C; Baird, RW; Stinear, TP; Williamson, DA; Currie, BJ; Krause, VL

(2021), Lancet Reg. Health-W. Pac.

DOI: 10.1016/j.lanwpc.2021.100229

The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong

Yang, BY; Tsang, TK; Wong, JY; He, YA; Gao, HZ; Ho, F; Lau, EHY; Wu, P; Sullivan, SG; Cowling, BJ

(2021), Lancet Reg. Health-W. Pac.

DOI: 10.1016/j.lanwpc.2021.100184

Scabies and impetigo in Samoa: A school-based clinical and molecular epidemiological study

Taiaroa, G; Matalavea, B; Tafuna'i, M; Lacey, JA; Price, DJ; Isaia, L; Leaupepe, H; Viali, S; Lee, D; Gorrie, CL; Williamson, DA; Jack, S

(2021), Lancet Reg. Health-W. Pac.

DOI: 10.1016/j.lanwpc.2020.100081

Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study

Lane, CR; Sherry, NL; Porter, AF; Duchene, S; Horan, K; Andersson, P; Wilmot, M; Turner, A; Dougall, S; Johnson, SA; Sait, M; da Silva, AG; Ballard, SA; Hoang, T; Stinear, TP; Caly, L; Sintchenko, V; Graham, R; McMahon, J; Smith, D; Leong, LEX; Meumann, EM; Cooley, L; Schwessinger, B; Rawlinson, W; van Hal, SJ; Stephens, N; Catton, M; Looker, C; Crouch, S; Sutton, B; Alpren, C; Williamson, DA; Seemann, T; Howden, BP

(2021), Lancet Public Health, E547-E556

DOI: 10.1016/S2468-2667(21)00133-X

Key parameters for genomics-based real-time detection and tracking of multidrug-resistant bacteria: a systematic analysis

Gorrie, CL; Da Silva, AG; Ingle, DJ; Higgs, C; Seemann, T; Stinear, TP; Williamson, DA; Kwong, JC; Grayson, ML; Sherry, NL; Howden, BP

(2021), Lancet Microbe, E575-E583

DOI: 10.1016/S2666-5247(21)00149-X

Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial

Chappell, KJ; Mordant, FL; Li, ZY; Wijesundara, DK; Ellenberg, P; Lackenby, JA; Cheung, STM; Modhiran, N; Avumegah, MS; Henderson, CL; Hoger, K; Griffin, P; Bennet, J; Hensen, L; Zhang, WJ; Nguyen, THO; Marrero-Hernandez, S; Selva, KJ; Chung, AW; Tran, MH; Tapley, P; Barnes, J; Reading, PC; Nicholson, S; Corby, S; Holgate, T; Wines, BD; Hogarth, PM; Kedzierska, K; Purcell, DFJ; Ranasinghe, C; Subbarao, K; Watterson, D; Young, PR; Munro, TP

(2021), Lancet Infect. Dis., 1383-1394

DOI: 10.1016/S1473-3099(21)00200-0

Treponema pallidum detection in lesion and non-lesion sites in men who have sex with men with early syphilis: a prospective, cross-sectional study

Towns, JM; Leslie, DE; Denham, I; Wigan, R; Azzato, F; Williamson, DA; Lee, D; Chow, EPF; Fairley, CK; Graves, SR; Zhang, L; Chen, MY

(2021), Lancet Infect. Dis., 1324-1331

DOI: 10.1016/S1473-3099(20)30838-0

The case for an HIV cure and how to get there

Dybul, M; Attoye, T; Baptiste, S; Cherutich, P; Dabis, F; Deeks, SG; Dieffenbach, C; Doehle, B; Goodenow, MM; Jiang, A; Kemps, D; Lewin, SR; Lumpkin, MM; Mathae, L; McCune, JM; Ndung'u, T; Nsubuga, M; Peay, HL; Pottage, J; Warren, M; Sikazwe, I

(2021), Lancet HIV, e51-e58

DOI: 10.1016/S2352-3018(20)30232-0

Multi-stakeholder consensus on a target product profile for an HIV cure

Lewin, SR; Attoye, T; Bansbach, C; Doehle, B; Dube, K; Dybul, M; SenGupta, D; Jiang, A; Johnston, R; Lamplough, R; McCune, JM; Nabel, GJ; Ndung'u, T; Pottage, J; Ripin, D; Rooney, JF; Sikazwe, I; Nsubuga, M; Warren, M; Deeks, SG

(2021), Lancet HIV, 42-50

DOI: 10.1016/S2352-3018(20)30234-4

IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication

Meischel, T; Fritzlar, S; Villalon-Letelier, F; Tessema, MB; Brooks, AG; Reading, PC; Londrigan, SL

(2021), J. Virol.

DOI: 10.1128/JVI.00837-21

Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020

Siegers, JY; Dhanasekaran, V; Xie, RP; Deng, YM; Patel, S; Ieng, V; Moselen, J; Peck, H; Aziz, A; Sarr, B; Chin, S; Heng, S; Khalakdina, A; Kinzer, M; Chau, D; Raftery, P; Duong, V; Sovann, L; Barr, IG; Karlsson, EA

(2021), J. Virol.

DOI: 10.1128/JVI.01267-21

Characterization of Hepatitis B Precore/Core-Related Antigens

Hong, XP; Luckenbaugh, L; Mendenhall, M; Walsh, R; Cabuang, L; Soppe, S; Revill, PA; Burdette, D; Feierbach, B; Delaney, W; Hu, JM

(2021), J. Virol.

DOI: 10.1128/JVI.01695-20

Risk mapping for COVID-19 outbreaks in Australia using mobility data

Zachreson, C; Mitchell, L; Lydeamore, MJ; Rebuli, N; Tomko, M; Geard, N

(2021), J. R. Soc. Interface

DOI: 10.1098/rsif.2020.0657

Real-world application of the Xpert (R) HBV viral load assay on serum and dried blood spots

Jackson, K; Tekoaua, R; Li, X; Locarnini, S

(2021), J. Med. Virol., 3707-3713

DOI: 10.1002/jmv.26662

Evaluation of ResistancePlus MG FleXible, a 'near- patient' test for the detection of Mycoplasma genitalium and macrolide resistance mutations, using freshly collected clinical samples

Murray, GL; Doyle, M; Bodiyabadu, K; Vodstrcil, LA; Garland, SM; Danielewski, J; Machalek, DA; McGuinness, C; Plummer, EL; De Petra, V; Williamson, DA; Bradshaw, CS

(2021), J. Med. Microbiol.

DOI: 10.1099/jmm.0.001271

Simultaneous identification of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Trichomonas vaginalis. multicenter evaluation of the Alinity m STI assay

Goldstein, E; Martinez-Garcia, L; Obermeier, M; Glass, A; Krugel, M; Maree, L; Gunson, R; Onelia, F; Pacenti, M; Nelson, KS; Joseph, AM; Palm, MJ; Lucic, D; Marlowe, N; Dhein, J; Reinhardt, B; Pfeifer, K; Galan, JC; Azzato, F

(2021), J. Lab. Med., 213-223

DOI: 10.1515/labmed-2020-0136

Factors associated with knowledges and attitudes about measles and rubella immunization in a non-health care occupational setting in Japan

Yahata, Y; Fielding, JE; Kamiya, H; Takimoto, N; Ishii, J; Fukusumi, M; Sunagawa, T

(2021), J. Infect. Chemother., 684-689

DOI: 10.1016/j.jiac.2020.12.003

Infection courses, virological features and IFN-alpha responses of HBV genotypes in cell culture and animal models

Zhang, M; Zhang, ZS; Imamura, M; Osawa, M; Teraoka, Y; Piotrowski, J; Ishida, Y; Sozzi, V; Revill, PA; Saito, T; Chayama, K; Liang, TJ

(2021), J. Hepatol., 1335-1345

DOI: 10.1016/j.jhep.2021.07.030

A PCR assay to quantify patterns of HBV transcription

D'Arienzo, V; Magri, A; Harris, JM; Wing, PAC; Ko, C; Rubio, CO; Revill, PA; Protzer, U; Balfe, P; McKeating, JA

(2021), J. Gen. Virol.

DOI: 10.1099/jgv.0.001373

Reflex Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae by Use of the SpeeDx ResistancePlus GC Assay

Lee, DYJ; Ashcroft, MM; Chow, EPF; Sait, M; De Petra, V; Tschaepe, M; Lange, S; Taiaroa, G; Bradshaw, CS; Whiley, DM; Fairley, CK; Howden, BP; Chen, MY; Pasricha, S; Williamson, DA

(2021), J. Clin. Microbiol.

DOI: 10.1128/JCM.00089-21

Molecular Phylogenetics of Hepatitis D Virus in New Zealand and the Implications for Pacific Island Countries

Jackson, K; Littlejohn, M; Gane, E; Locarnini, S

(2021), Intervirology, 102-107

DOI: 10.1159/000513685

Changes in infection-related hospitalizations in children following pandemic restrictions: an interrupted time-series analysis of total population data

Todd, IMF; Miller, JE; Rowe, SL; Burgner, DP; Sullivan, SG

(2021), Int. J. Epidemiol., 1435-1443

DOI: 10.1093/ije/dyab101

COVID-19 in Australia: our national response to the first cases of SARS-CoV-2 infection during the early biocontainment phase

Shaban, RZ; Li, CC; O'Sullivan, MVN; Gerrard, J; Stuart, RL; Teh, J; Gilroy, N; Sorrell, TC; White, E; Bag, S; Hackett, K; Chen, SCA; Kok, J; Dwyer, DE; Iredell, JR; Maddocks, S; Ferguson, P; Varshney, K; Carter, I; Barratt, R; Robertson, M; Baskar, SR; Friend, C; Robosa, RS; Sotomayor-Castillo, C; Nahidi, S; Macbeth, DA; Alcorn, KAD; Wattiaux, A; Moore, F; McMahon, J; Naughton, W; Korman, TM; Catton, M; Kanapathipillai, R; Romanes, F; Rowe, E; Catford, J; Kennedy, B; Qiao, M; Shaw, D

(2021), Intern. Med. J., 42-51

DOI: 10.1111/imj.15105

Viperin binds STING and enhances the type-I interferon response following dsDNA detection

Crosse, KM; Monson, EA; Dumbrepatil, AB; Smith, M; Tseng, YY; van der Hoek, KH; Revill, PA; Saker, S; Tscharke, DC; Marsh, ENG; Beard, MR; Helbig, KJ

(2021), Immunol. Cell Biol., 373-391

DOI: 10.1111/imcb.12420

Analgesic and adjuvant properties of exercise with vaccinations in healthy young population

Lee, VY; Bohn-Goldbaum, E; Fong, J; Barr, IG; Booy, R; Edwards, KM

(2021), Human Vaccines Immunother., 2058-2064

DOI: 10.1080/21645515.2020.1859322

Characterization and Application of Precore/Core-Related Antigens in Animal Models of Hepatitis B Virus Infection

Hong, XP; Luckenbaugh, L; Perlman, D; Revill, PA; Wieland, SF; Menne, S; Hu, JM

(2021), Hepatology, 99-115

DOI: 10.1002/hep.31720

Origins and Evolution of the Primate Hepatitis B Virus

Locarnini, SA; Littlejohn, M; Yuen, LKW

(2021), Front. Microbiol.

DOI: 10.3389/fmicb.2021.653684

Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin

Netter, HJ; Barrios, MH; Littlejohn, M; Yuen, LKW

(2021), Front. Microbiol.

DOI: 10.3389/fmicb.2021.652962

Editorial: Origin and Evolution of Hepatitis Viruses

Osiowy, C; Yuen, L

(2021), Front. Microbiol.

DOI: 10.3389/fmicb.2021.740255

Autochthonous and Travel Acquired Hepatitis E Virus in Australia

O'Keefe, J; Tracy, L; Yuen, L; Bonanzinga, S; Li, X; Chong, B; Nicholson, S; Jackson, K

(2021), Front. Microbiol.

DOI: 10.3389/fmicb.2021.640325